Aerie Pharmaceuticals

Vince Anido Jr, PhD

Show Description +

Vince Anido Jr, PhD, Chief Executive Officer, Aerie Pharmaceuticals, provides an update on the company's glaucoma products and a look into the early-stage pipeline for retina diseases.

Posted: 7/23/2018

Keywords:

Aerie Pharmaceuticals

Up Next

Name: Aerie Pharmaceuticals
Uploaded: 2018-07-23T15:18:00+00:00
Description: Vince Anido Jr, PhD, Chief Executive Officer, Aerie Pharmaceuticals, provides an update on the company's glaucoma products and a look into the early-stage pipeline for retina diseases.

Spark Therapeutics

Paulo Falabella, MD, PhD

Allegro

Vicken Karageozian, MD

Eyedaptic

Jay Cormier

GenSight Biologics

Barrett Katz, MD

RFE Pharma

Alan Franklin, MD, PhD

EyePoint Pharmaceuticals

Tom Hadley

Zeiss

ZeaVision Holdings

Pinakin Davey, OD, PhD

iRenix

Stephen Smith, MD

Clearside Biomedical

Brion Raymond

Back to All Videos

Aerie Pharmaceuticals

Vince Anido Jr, PhD

Vince Anido Jr, PhD, Chief Executive Officer, Aerie Pharmaceuticals, provides an update on the company's glaucoma products and a look into the early-stage pipeline for retina diseases.

Posted: 7/23/2018

Keywords:

Aerie Pharmaceuticals

Please log in to leave a comment.

Meeting Coverage:

Ophthalmology Innovation Summit - Retina

Aerie Pharmaceuticals

Up Next

Aerie Pharmaceuticals

More From OIS Retina: 2018 Coverage